MARATTO

article · Bulletin of Faculty of Science Zagazig University

Innovative strategies for biotechnological production of hyaluronic acid from different sources

20241 citationOpen accessZagazig University

Abstract

Hyaluronic acid (HA) is a biological macromolecule belongs to a class of polysaccharides called glycosaminoglycans/mucopolysaccharides, a linear polysaccharide consist of repeating disaccharide unites. In the healthcare and pharmaceutical industries, HA has a wide range of uses. It is used in a variety of medical applications such as osteoarthritis (OA) treatment, cancer treatment, ophthalmology (aiding in eye surgery), wound healing, ageing processes, cosmetics and tissue engineering applications. HA has also recently been investigated as a drug delivery agent for a variety of routes including nasal, oral, pulmonary, ocular, topical and parenteral. HA can be produced by different methods such as physical, chemical and biological methods. Microorganisms have been used to produce HA, and this process has long been researched. The production of HA is enhanced by genetic engineering technique and optimizing the nutritional and environmental parameters of the fermentation medium. The aim of this review is to high light on the different strategies for HA production

Research topics

  • Proteoglycans and glycosaminoglycans research
  • Glycosylation and Glycoproteins Research
  • Carbohydrate Chemistry and Synthesis

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bfszu.2023.198824.1260

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.